Abstract:BackgroundRecent studies have indicated that deubiquitinating enzymes (DUBs) are related to the stem-cell pathway network and chemo-resistance in cancer. Ubiquitin-specific peptidase 37 (USP37), a novel DUB, was identified to be a potential factor associated with tumor progression. However, the biological functions of USP37 in breast cancer remain unclear.MethodsThe distribution of USP37 expression in breast cancer and the correlation between USP37 expression and the overall survival rate were detected by The Cancer Genome Atlas (TCGA) database. Gene set enrichment analysis (GSEA) was utilized to evaluate potential mechanism of USP37 in breast cancer. The USP37 expression in breast cancer tissues and breast cancer cell lines were detected by immunohistochemistry and western blotting. Sorting of breast cancer stem cells (BCSCs) were by using MACS assay. In vitro and in vivo assays were performed to examine the biological functions of USP37 in breast cancer cells. MG132, CHX chase, immunofluorescence staining and co-immunoprecipitation assays were used to test the interaction between USP37 and Gli-1.ResultsBioinformatics analysis demonstrated that USP37 gene was elevated in breast cancer tissues and its overexpression was strongly correlated with the increased mortality rate. GSEA analysis showed that USP37 expression was positively associated with cell growth and metastasis while negatively related to cell apoptosis in the TCGA breast cancer samples. USP37 expression was elevated in breast cancer tissues and breast cancer cell lines. Moreover, we also detected that USP37 was overexpressed in BCSCs. USP37 regulated the ability of cell invasion, epithelial-mesenchymal transition (EMT), stemness and cisplatin sensitivity in breast cancer cell lines. Additionally, USP37 knockdown inhibited tumorigenicity and increased anticancer effect of cisplatin in vivo. Knockdown of USP37 significantly decreased hedgehog (Hh) pathway components Smo and Gli-1. Gli-1 was stabilized by USP37 and they interacted with each other. Further studies indicated that USP37 knockdown could inhibit the stemness, cell invasion and EMT in breast cancer via downregulation of Hh pathway.ConclusionsThese findings reveal that USP37 is highly expressed in BCSCs and is correlated with poor prognosis in breast cancer patients. USP37 can regulate the stemness, cell invasion and EMT via Hh pathway, and decreased USP37 confers sensitivity to cisplatin in breast cancer cells. USP37 is required for the regulation of breast cancer progression, as well as a critical target for clinical treatment of breast cancer.

USP37 Promotes Angiogenesis and Metastasis in Colorectal Cancer by Facilitating Β-Catenin Stability.

Correction to: USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization

USP36 plays an oncogenic role in colorectal cancer cells

USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway.

Abnormally Elevated USP37 Expression in Breast Cancer Stem Cells Regulates Stemness, Epithelial-Mesenchymal Transition and Cisplatin Sensitivity

USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28

Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor.

USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer

Ubiquitin-specific protease 21 promotes tumorigenicity and stemness of colorectal cancer by deubiquitinating and stabilizing ZEB1

USP36 Inhibits Apoptosis by Deubiquitinating Ciap1 and Survivin in Colorectal Cancer Cells

USP47-Mediated Deubiquitination and Stabilization of TCEA3 Attenuates Pyroptosis and Apoptosis of Colorectal Cancer Cells Induced by Chemotherapeutic Doxorubicin.

USP14 Promotes the Proliferation of Cervical Cancer Via Upregulating Β-Catenin

USP35 Promotes HCC Development by Stabilizing ABHD17C and Activating the PI3K/AKT Signaling Pathway.

Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer

USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway

Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 is Required for Potentiating Colorectal Oncogenesis.

Ubiquitin-specific Protease 15 Contributes to Gastric Cancer Progression by Regulating the Wnt/β-catenin Signaling Pathway.

USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53

USP39 stabilizes β-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression

USP39 Mediates P21-Dependent Proliferation and Neoplasia of Colon Cancer Cells by Regulating the P53/p21/cdc2/cyclin B1 Axis.

USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth